To provide Developmental Services (DS) waiver direct service providers, or direct service staff employed by DS waiver providers, who do not currently hold a professional medical license and who provide direct services to DS waiver recipients while ...

 

DEPARTMENT OF CHILDREN AND FAMILY SERVICES
Agency for Persons with Disabilities

RULE NO: RULE TITLE
65G-7.001: Definitions
65G-7.002: Determination of Need for Assistance with Medication Administration; Informed Consent
65G-7.003: Medication Administration Training Course
65G-7.004: Validation Requirements
65G-7.005: Medication Administration Procedures
65G-7.006: Medication Errors
65G-7.007: Storage Requirements
65G-7.008: Documentation and Record Keeping
65G-7.009: Off-site Medication Administration
PURPOSE AND EFFECT: To provide Developmental Services (DS) waiver direct service providers, or direct service staff employed by DS waiver providers, who do not currently hold a professional medical license and who provide direct services to DS waiver recipients while in their own or family homes, foster homes, group homes, independent living arrangements, supported living arrangements, and adult day training facilities, with guidelines for: medication administration training and medication administration skills validation requirements for unlicensed direct service providers; requirements for administration of medications; requirements for the supervision of the self-administration of medication by validated direct service providers; special requirements for recipients who require medication while traveling or away for a visit; informed consent; request for exemption; and additional requirements.

SUMMARY: The rules will implement uniform standards for unlicensed direct service providers’ supervision of self-administration of medications by DS waiver recipients, and administration of medications to DS waiver recipients.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COST: No Statement of Estimated Regulatory Costs was prepared.

Any person who wishes to provide information regarding a statement estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so within 21 days of this notice.

SPECIFIC AUTHORITY: 393.506(5) FS.
LAW IMPLEMENTED: 393.506(1) FS.
IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE WEEKLY.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Michelle Ledbetter, Registered Nurse Consultant, Agency for Persons with Disabilities, 4030 Esplanade Way, Tallahassee, Florida 32399-0950, or telephone number [phone]

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS AVAILABLE AT NO CHARGE FROM THE CONTACT PERSON LISTED ABOVE.